GLP-1 microdosing refers to using a significantly lower dose of a GLP-1 medication than the FDA-approved schedule, often to minimize side effects while still achieving some metabolic benefit
availability over the counter in the UK is limited and patients should check with a pharmacist
metformin for women with PCOS A 2017 randomized controlled trial comparing metformin to a GLP-1 agonist found that obese women with PCOS who took the GLP-1 agonist lost an additional 2 kg (4.4 lbs), had more frequent menstrual cycles, and had a higher rate of achieving pregnancy (43.6% vs
Im going to kind of reassess every time its due to order another box and see like, okay, do I want to spend this? he said
And on top of that was the junk I was buying at the grocery store to stock up the house
Jaime Almandoz, an obesity medicine specialist at the University of Texas Southwestern Medical Center